1. Introduction
Enterovirus alphacoxsackie (EV-A) is a group of non-enveloped, positive-sense, and single-stranded RNA viruses belonging to the
Enterovirus genus of the
Picornaviridae family. EV-A can cause diseases ranging from asymptomatic infections to severe neurological disorders such as aseptic meningitis and encephalitis [
1,
2], as well as mucocutaneous diseases like hand, foot, and mouth disease (HFMD) [
3,
4,
5]. In recent decades, large-scale EV-A outbreaks have frequently been reported, particularly in East and Southeast Asia [
6,
7,
8,
9], resulting in a substantial public health burden.
The EV-A genome is approximately 7.4–7.5 kb in length, containing a 5′ untranslated region (UTR), a single open reading frame (ORF), and a 3′ UTR. The ORF encodes a polyprotein precursor that is processed by viral proteases into three segments (P1–P3). The P1 segment encodes four structural proteins (VP1-VP4), whereas the P2 (2A–2C) and P3 (3A–3D) segments encode non-structural proteins [
10,
11,
12]. Based on sequence similarity in the P1 segment and non-structural 2C/3CD regions, the International Committee on Taxonomy of Viruses (ICTV) has classified EV-A into 25 distinct serotypes, including
Coxsackievirus A (CVA) and other Enterovirus A serotypes [
13]. Although these serotypes share conserved genomic features, they exhibit distinct epidemiological and clinical characteristics.
EV-A infection is associated with a broad spectrum of diseases, with clinical outcomes influenced by multiple factors, including viral serotype, biological characteristics, and host immune status. Notable differences exist in the clinical profiles among distinct serotypes. Besides causing typical HFMD, EV-A71, the most extensively studied serotype, frequently leads to severe neurological complications such as brainstem encephalitis, aseptic meningitis, and neurogenic pulmonary edema [
14]. In contrast, CVA16, another major causative agent of HFMD [
3], usually leads to mild clinical manifestations characterized by faint rash and short-term fever, with rare cases of severe complications [
15]. These divergent clinical and biological phenotypes likely reflect serotype-specific differences in viral replication kinetics, polyprotein processing efficiency, and capacity for host immune modulation.
Among the non-structural proteins, the 2A protease plays a critical role in regulating these processes. As a cysteine protease, it cleaves the viral polyprotein to ensure proper assembly of viral particles. Inter-serotype variations in cleavage efficiency potentially contribute to differences in viral replication rates [
16]. Moreover, 2A protease modulates host cellular processes by targeting key factors such as the eukaryotic initiation factor eIF4G [
17], thereby inhibiting host protein synthesis in favor of viral translation. Additionally, 2A interferes with innate immune pathways, notably the RIG-I/MAVS signaling axis [
18], and alters cytoskeletal components [
19] to facilitate viral release. Given these pleiotropic roles, 2A protease is regarded as an essential determinant of viral fitness and a promising target for antiviral strategies. Notably, inter-serotype variations in 2A’s protease sequence, catalytic activity, and substrate specificity have been implicated in the observed differences in replication rates, tissue preference, and capacity for immune evasion [
16].
In recent years, other serotypes like CVA6 and CVA10 have emerged as significant causative agents of HFMD [
4], exhibiting clinical features distinct from those of EV-A71 and CVA16. CVA6 infection often results in atypical HFMD, characterized by a more extensive rash distribution and complex lesion morphology, and is frequently accompanied by onychomadesis and mucosal erosion, suggesting enhanced tropism for skin and mucosal tissues [
20]. Besides HFMD, herpangina is also observed in CVA10 infection, characterized by prolonged fever duration in certain cases and clinical manifestations that may mimic herpesvirus infections [
21], requiring differential diagnosis. The emergence of these serotypes with diverse clinical presentations highlights the importance of serotype-specific factors.
As with many RNA viruses, EV-A exhibits a high mutation rate, driven by the lack of proofreading activity in its RNA-dependent RNA polymerase [
22,
23]. Genetic variability arises predominantly through point mutations and frequent recombination events, contributing to antigenic drift, immune escape, and enhanced adaptability [
24,
25,
26]. However, traditional sequence analyses often treat all observed mutations equally without distinguishing between neutral, functionally irrelevant polymorphisms and mutations that may impact viral phenotypes. This limitation highlights the need for refined analytical strategies capable of identifying functionally relevant variations. In practice, the study of single amino acid polymorphisms (SAPs) [
27,
28] facilitates the identification of non-synonymous mutations related to alteration of protein function. SAPs have been employed in various virological analyses to elucidate determinants of virulence, receptor usage, and immune evasion [
29,
30,
31]. However, a key challenge in current SAP analyses lies in distinguishing functional variations from the background of neutral mutations.
To address the limitations above, we developed Single Amino Acid Polymorphism Statistics (SAAPS), an information-entropy (IE)-based algorithmic pipeline, to identify the functional kSAPs of EV-A 2A. The core principle of the algorithm is that the IE of the kSAPs can be neither too low (highly conserved sites not leading to variance) nor too high (random neutral mutations). Using EV-A 2A proteases from 25 serotypes as a proof-of-concept dataset, we demonstrate that SAAPS-driven clustering can identify functional associations that are not evident from conventional phylogenetics and can guide experimental validation. This work positions SAAPS as a useful tool for prioritizing functionally relevant SAPs, guiding mechanistic discovery, and can be applied to highly conserved proteins like EV-A 2A.
2. Materials and Methods
2.1. Data Collection and Sequence Processing
Information on EV-A serotypes was obtained from the Picornaviridae database (
https://picornaviridae.com/), and the amino acid sequences of 2A proteases were obtained from the National Center for Biotechnology Information (NCBI) (
https://www.ncbi.nlm.nih.gov/). A total of 25 EV-A serotypes were selected for analysis to ensure comprehensive representation of genetic diversity. Sequences containing ambiguous characters, low-quality regions, or incomplete coding regions were filtered out to maintain high data integrity. Any sequence with unidentified codons or incorrect formatting was replaced with higher-quality alternatives from the database. All the viral sequences used in this study are listed in
Supplementary Table S1. These sequences correspond to prototype strains for each EV-A serotype. While a single representative sequence does not capture natural intra-serotype variation, it provides a consistent benchmark for method comparison.
2.2. Sequence Analysis and Phylogenetic Classification
To investigate the evolutionary relationships among EV-A serotypes, multiple sequence alignment was performed using MAFFT [
32], followed by sequence identity analysis using BioAider [
33]. The phylogenetic trees were constructed using Maximum Likelihood (ML) and Neighbor-Joining (NJ) methods. Evolutionary distances were estimated using substitution models selected via model-fitting analyses performed with ProtTest [
34] and MEGA 7 [
35] (the model results predicted can be found in
Supplementary Tables S2 and S3). The robustness of tree topologies was assessed using bootstrap resampling to ensure reliable clustering of viral strains. Comparative analysis between traditional phylogenetic approaches and SAP-based classification was conducted to evaluate the efficacy of SAP clustering in delineating viral subgroups.
2.3. SAAPS Workflow Used in This Study
Single Amino Acid Polymorphism Statistics (SAAPS) is a Python- and R-based workflow developed to analyze polymorphic amino acid sites in aligned protein sequences. In general, SAAPS can identify single amino acid polymorphisms (SAPs), calculate site-level Shannon entropy and information content (IC), filter polymorphic sites by user-defined IC ranges, convert selected residues into numerical features, and perform dimensionality-reduction and clustering analyses. General software functions and command-line usage are described in the Supplementary SAAPS Manual and at
https://github.com/xiaosheep01/SAAPS (accessed on 25 August 2025).
In this study, we used a defined SAAPS workflow for EV-A 2A proteases. The workflow consisted of sequence alignment, SAP identification, entropy and IC calculation, IC-based kSAP selection, AAindex1 encoding, PCA dimensionality reduction, and OPTICS clustering. This section describes only the implementation used for the present EV-A 2A analysis.
2.4. Entropy, Information Content, and kSAP Selection
In this study, the identification of kSAPs in the EV-A 2A protease was performed using Shannon information entropy and SAAPS. Shannon entropy, a concept originating from information theory, quantifies the uncertainty or diversity within a system. In this study, we employed “Information Content” (IC) as a metric to assess the level of polymorphism at each site. For each aligned position , the frequency of amino acid was denoted as . Gaps and ambiguous residues were excluded. The number of observed amino acid states at position was denoted as , and the number of possible amino acid states used for IC calculation was denoted as . Because only the 20 standard amino acids were considered, .
Shannon entropy at position
was calculated as:
Information content was calculated as:
Under this definition, a conserved site has an entropy close to 0 and IC close to , whereas a highly variable site has a higher entropy and lower IC. Thus, a higher IC indicates greater conservation, while a lower IC indicates greater amino acid variability.
To select kSAPs, positions were grouped by . The mean IC was calculated for each group. The upper cutoff was derived from the mean IC of sites with two observed amino acid states, with a 5% operational tolerance, yielding 4.022. The lower cutoff was derived from the mean IC values of sites with four and five observed amino acid states, with a 5% operational tolerance, yielding 2.735. This gave an empirical candidate interval of 2.735–4.022.
To validate the biological relevance of this interval, we performed a sensitivity analysis by testing multiple IC ranges (from 1.677 to 4.322 to 3.274–4.322) and examined their clustering patterns against an external biological feature—the known host ranges of the serotypes (non-human primate, baboon, human). This information was used only for post hoc assessment, not for threshold derivation. Only the 2.735–4.022 range produced clustering that was consistent with the host range information (see
Section 3.2), thereby confirming its operational suitability for this EV-A 2A dataset. This interval is dataset-specific and should not be interpreted as a universal threshold for other proteins or sequence collections. For other datasets, users are encouraged to perform a similar sensitivity analysis.
2.5. AAindex Encoding, PCA, and OPTICS Clustering
Residues at the selected kSAP positions were encoded using the Amino Acid Index (AAindex) [
36]. Features were selected from the AAindex1 database (release 20170213), which contains descriptors of amino acid physicochemical properties. All 566 AAindex1 physicochemical descriptors were initially considered. Descriptors containing missing values for the 20 standard amino acids were removed, leaving 553 descriptors. Each residue at each selected kSAP position was therefore represented by a 553-dimensional vector.
For each EV-A serotype, AAindex vectors from the selected kSAP positions were concatenated in alignment order. Because 56 kSAP positions were selected, each serotype was represented by 56 × 553 = 30,968 features. The final matrix contained 25 rows, corresponding to the 25 EV-A serotypes, and 30,968 columns, corresponding to the concatenated AAindex features. AAindex feature values were standardized before PCA.
PCA was used as a deterministic linear dimensionality-reduction step to summarize the dominant variation in the high-dimensional AAindex matrix. The first two principal components explained 61.55% of the total variance (PC1, 42.71%; PC2, 18.84%) and were used for two-dimensional visualization and exploratory clustering. OPTICS was then applied to PC1 and PC2 using Euclidean distance, min_samples = 2, max_eps = 30, cluster_method = “dbscan”, and min_cluster_size = 2. Under these settings, PCA and OPTICS were deterministic and did not require random initialization or random seeds.
This PCA-OPTICS analysis was used as a proof-of-concept application of SAAPS to EV-A 2A proteases. It was not intended as a comprehensive benchmark of all possible dimensionality-reduction and clustering methods. Therefore, the resulting clusters were interpreted as candidate functional groupings supported by kSAP patterns and transcriptomic comparisons rather than as a definitive or universally optimal classification.
2.6. RNA-Seq Library Preparation, Sequencing, and Data Analysis
To validate the clustering results of polymorphic sites and assess their association with functional phenotypes, bulk RNA-seq was performed on HEK-293T cells expressing the 2A proteases from all 25 EV-A serotypes. Two independent biological replicates were prepared for each serotype, along with an empty vector control. Cells were harvested 24 h post-transfection, and total RNA was extracted using TRIzol reagent (15596026, Invitrogen, Shanghai, China), followed by DNase I treatment. RNA quality was determined by examining A260/A280 with a Nanodrop OneC spectrophotometer (Thermo Fisher Scientific, Shanghai, China). RNA integrity was confirmed by 1.5% agarose gel electrophoresis. Qualified RNAs were finally quantified by Qubit3.0 with the Qubit RNA Broad Range Assay kit (Q10210, Life Technologies, Shanghai, China).
A total of 2 μg of RNA was used for stranded Bulk RNA sequencing library preparation using the KC-Digital Stranded mRNA Library Prep Kit for Illumina (DR08502, Wuhan Seqhealth, Wuhan, China) following the manufacturer’s instructions. This kit uses a unique molecular identifier (UMI) of 8 random bases to label the pre-amplified cDNA molecules, enabling removal of PCR duplication bias. The library products corresponding to 200–500 bp were enriched, quantified, and finally sequenced on a DNBSEQ-T7 sequencer (MGI Tech, Shenzhen, China) with the PE150 model.
Raw reads were filtered with Trimmomatic (version 0.36) to remove low-quality reads and reads contaminated with adaptor sequences. Clean reads were first clustered according to the UMI sequences, in which reads with the same UMI sequence were grouped into the same cluster. Reads in the same cluster were compared to each other by pairwise alignment, and then reads with a sequence identity over 95% were extracted to a new sub-cluster. After all sub-clusters were generated, multiple sequence alignment was performed to achieve one consensus sequence for each sub-cluster. After these steps, any errors and biases introduced by PCR amplification or sequencing were eliminated.
The de-duplicated consensus sequences were used for standard RNA-seq analysis. They were mapped to the reference genome of homo sapiens (GRCh38_release110) using STAR software (version 2.5.3a) with default parameters. Gene-level read counts were quantified with featureCounts (Subread-1.5.1), and RPKM values were calculated. Genes differentially expressed between groups were identified using the edgeR package (version 3.12.1). A gene was considered significantly differentially expressed if it satisfied |log2FC| > 1 and a false discovery rate (FDR) < 0.05.
Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted utilizing the R package clusterProfiler [
37,
38]. Subsequently, for each identified cluster, intersection analyses of KEGG pathways and DEGs were carried out to determine key pathways or genes commonly shared among different clusters.
2.7. Cell Culture
HEK-293T (National Collection of Authenticated Cell Cultures, Shanghai, China) cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; C11995500BT, Gibco, Shanghai, China), supplemented with 10% fetal bovine serum (A5256701, Gibco, Shanghai, China) and 1% penicillin–streptomycin (SL6040, Coolaber, Beijing, China). All cells were cultured at 37 °C in a humidified incubator with 5% CO2.
2.8. Plasmids and Transfection
All plasmids used in this study were commercially synthesized by Tsingke Biotechnology Co., Ltd. (Beijing, China) and verified by Sanger sequencing. For plasmid transfection, HEK-293T cells were seeded in 12-well plates (70% confluence) one day before transfection. On the day of transfection, the cell culture medium was changed, and cells were transfected with the indicated plasmids (1000 ng/well) using Lipofectamine LTX and PLUS Transfection Reagent (Invitrogen, Shanghai, China) according to the manufacturer’s instructions.
2.9. Western Blotting
At 24 h post-transfection, cells were washed with phosphate-buffered saline (PBS) and lysed with RIPA buffer (AWB0138a, Abiowell, Changsha, China) supplemented with 1% protease inhibitor cocktail and phosphatase inhibitor cocktail (78441, Thermo Fisher Scientific, Shanghai, China. The lysates were incubated on ice for 30 min and centrifuged at 12,000× g for 15 min at 4 °C. Supernatants were boiled with 6× loading buffer at 98 °C for 10 min. Proteins were resolved on SDS-PAGE gels and transferred to polyvinylidene difluoride (PVDF) membranes (IPVH00010, Merck, Shanghai, China) that had been pre-activated with methanol. The PVDF membranes were then blocked with 5% skim milk for 1 h, followed by incubation with primary antibody overnight at 4 °C. After three washes with 1× TBST (G0004-1L, Servicebio, Wuhan, China), the membranes were incubated with secondary antibody for 1 h at room temperature. The membranes were then washed three times with 1× TBST, and protein bands were visualized using an ECL substrate (K1232, APExBIO, Houston, TX, USA) and a chemiluminescence imaging system (OI 600MF, Bio-OI, Guangzhou, China). Mouse monoclonal anti-Myc antibody (M20002S 19C2, Abmart, Shanghai, China) was used at a 1:2000 dilution in 1× TBST. HRP-conjugated beta actin monoclonal antibody (AN00295HP, Elabscience, Wuhan, China) was used at a 1:2000 dilution in 1× TBST. HRP-conjugated goat anti-mouse IgG secondary antibody (A21010) was purchased from Abbkine and used at a 1:5000 dilution in 1× TBST.
4. Discussion
The main contribution of this study is the development of SAAPS, an information-entropy-based pipeline that prioritizes polymorphic sites likely under functional selection. As a proof-of-concept, we applied SAAPS to EV-A 2A proteases. Traditional phylogenetic analyses, typically based on whole-genome or conserved region similarity, often fail to capture serotype-specific functional differences. In contrast, SAAPS-derived clustering showed closer alignment with transcriptomic phenotypes and uncovered a serotype (EV-A89) with an altered expression pattern.
Entropy-based filtering distinguishes functional polymorphisms from background noise. Of the 88 polymorphic sites identified in EV-A 2A protease, 56 (63.6%) met our IC threshold criteria (2.735–4.022). This filtering strategy is grounded in evolutionary theory: sites with an IC < 2.735 (low entropy, near-complete conservation) likely represent structurally or catalytically essential residues where variation is strongly deleterious, consistent with the invariant catalytic triad (His-Asp-Cys) in picornaviral 2A proteases [
39,
40,
41]. Conversely, sites with an IC > 4.022 (high entropy, hypervariable) may reflect neutral drift or lineage-specific adaptations without functional consequences. The intermediate IC range thus captures sites under diversifying selection; precisely, the variants most likely to contribute to phenotypic diversity. The threshold boundaries were empirically derived from the dataset distribution, balancing the risk of splitting biological groups against merging distinct lineages. The lower bound (IC = 2.735) corresponds to sites with exactly two amino acid variants at near-equal frequencies (
p ≈ 0.5), representing the simplest case of functional polymorphism. The upper bound (IC = 4.022) approximates the entropy of four equally likely variants, beyond which additional diversity provides diminishing functional information. Notably, only the 2.735–4.022 range consistently classified EV-A124 with Group 2 viruses while maintaining EV-A125 as an outlier. This clustering pattern was consistent with both the transcriptomic profiles and, independently, with the known host ranges of these serotypes, where EV-A92/122/123/124 are non-human primate isolates, and EV-A125 is baboon-derived. These consistencies provide supportive evidence for the operational choice of this threshold, but do not imply a direct causal link between 2A polymorphisms and host tropism. Therefore, this threshold can be interpreted as a suitable operational threshold for this EV-A 2A dataset, but it should not be presented as a universally optimal threshold. For other proteins, other viruses, or expanded sets of EV-A sequences, the IC distribution should be recalculated and a similar threshold sensitivity analysis performed.
The divergence between phylogenetic groupings and SAAPS-based clustering arises because conventional phylogeny treats all positions equally, while SAAPS focuses on sites under diversifying selection (IC 2.735–4.022). This explains why, for example, EV-A90, EV-A92, and EV-A119 cluster together in SAAPS but not in the phylogenetic tree. A limitation of this study is that only one representative sequence per serotype was analyzed. This choice was made to ensure standardized and reproducible comparisons between SAAPS and conventional phylogeny, as the primary goal was to introduce and benchmark the SAAPS pipeline rather than to perform a comprehensive serotype-level evolutionary analysis. Nevertheless, we recognize that intra-serotype variation could affect the clustering results, and future work with multiple isolates per serotype will be needed to assess the robustness of our SAAPS-based groupings.
Using SAAPS for systematic identification, 88 polymorphic sites were detected within the 2A protease, of which 56 were classified as key SAP sites (kSAPs) based on information entropy metrics. These critical polymorphic residues exhibited a non-random distribution. Among the 56 key sites, only 5.36% resided in α-helices, whereas 57.14% were located in β-strands. This pronounced bias suggests the possibility that β-sheet structures accommodate functional variation more readily than α-helices in the 2A protease, potentially reflecting the catalytic architecture where strand flexibility modulates substrate access without compromising core stability [
16,
42]. As the 2A protease is known to orchestrate viral polyprotein processing, suppress host translation, and modulate innate immunity, mutations at these positions could represent candidate determinants that influence viral replication efficiency and immune evasion, although direct evidence is needed.
Classification of EV-A strains based on these filtered polymorphic sites revealed distinct groupings not captured by conventional phylogenetic trees. Strains such as EV-A90, EV-A92, EV-A119, and EV-A122 to EV-A125, which exhibited ambiguous relationships in genome-wide analyses, clustered coherently. Similarly, EV-A124 was reclassified into Group 2 (EV-A92, EV-A122, EV-A123), supported by 28 shared DEGs. Notably, CVA3 and CVA5 share 223 common DEGs—substantially higher than the 46 shared between phylogenetically closer CVA3/CVA10. Likewise, CVA14/CVA4 clustering is supported by 55 common DEGs, compared to only 21 between CVA14 and EV-A71, as predicted by traditional methods.
The outlier status of EV-A89 is particularly significant: although it belongs to the SCARB2-dependent receptor group containing neurovirulent EV-A71 and CVA7 [
43,
44], transcriptomic data indicate that it uniquely activates PTGS2-mediated inflammatory pathways, potentially offering a hypothesis to explain this outlier observation. Furthermore, we observed that EV-A89 2A exhibits an unusual expression behavior, producing a band of approximately 25 kDa instead of the expected 30 kDa observed for other EV-A 2As. Through domain-swap mapping, we found that replacement of the middle segment (residues 77–120) shifted the band from ~25 kDa to ~27.5 kDa, whereas the other chimeras retained the ~25 kDa band. This indicates that the 77–120 region contributes to the altered shift in the molecular weight. Within this region, mutational analysis identified three residues (85, 88, and 98) that contribute to the altered processing behavior. Each mutant produced two protein bands: one corresponding to 89-2A-Myc (~25 kDa) and another co-migrating with the 89-2A
Δ71(77–120) chimera (~27.5 kDa). Notably, these three residues are located within kSAPs identified by our SAAPS analysis. However, the exact molecular basis of the altered migration remains unknown. We acknowledge that additional experiments would be required to distinguish between possible mechanisms (e.g., protease-dead mutant control, degradation, altered post-translational modification). Further investigation is needed to determine the underlying mechanism.
These findings underscore the distinctive capability of SAAPS in resolving functional relevance: by selectively analyzing information entropy-filtered polymorphisms, SAAPS captures phenotypic associations undetectable by whole-genome phylogenetics. Hence, SAAPS could potentially provide a refined analytical framework for molecular epidemiology and outbreak risk assessment, although this remains a future application requiring validation with independent datasets and live virus models. These observations challenge the reliance on genome-wide sequence similarity alone for viral classification, highlighting the necessity of integrating evolutionary selection signals and protein functional domain information into taxonomic frameworks. The clustering results suggest that subtle, functionally relevant polymorphisms—rather than overall genetic identity—may generate hypotheses for future studies on viral phenotypes.
Moreover, while structural proteins have historically dominated enterovirus phylogenetic and antigenic studies [
45,
46], the centrality of non-structural proteins, particularly proteases like 2A, is increasingly apparent. The functional impact of polymorphisms within non-structural regions, especially those involved in host interaction and immune suppression, warrants closer attention in understanding viral adaptability and functional alteration. Importantly, the entropy-based selection of polymorphic sites demonstrated here refines clustering stability and biological relevance, correcting misclassifications introduced by indiscriminately incorporating all sequence variations. This approach not only enhances viral classification accuracy but also offers practical avenues for further research. Identifying serotype-specific or group-specific polymorphisms within functionally critical regions such as 2A may inform the design of broad-spectrum antiviral agents targeting conserved functional sites. Additionally, integrating polymorphism-based clustering with transcriptomic profiling provides a basis for phenotype-driven viral surveillance, offering the potential to generate hypotheses for future studies.
In this study, we expressed individual 2A proteases in HEK-293T cells to profile host transcriptomic alterations. HEK-293T cells are widely used for such studies due to their high transfection efficiency, robust protein expression, and well-characterized background, which together allow clear detection of 2A-mediated effects. It should be emphasized that this transcriptomic analysis is exploratory, with only two biological replicates per condition and no formal batch-effect correction; it serves as a hypothesis-generating screen rather than a definitive phenotype benchmark. While this approach successfully eliminates confounding effects from other viral proteins and enables direct attribution of observed changes to 2A sequence variations, it does not fully represent the complexity of viral infection. Whole-virus infection involves multiple steps (attachment, entry, replication, assembly) and the concerted action of many viral factors, including structural proteins and other non-structural proteins. Therefore, the transcriptomic signatures identified here should be interpreted as candidate functional differences that are hypothesis-generating and require validation in the context of whole-virus infection. Future work using reverse genetics or direct comparison with infection by authentic EV-A serotypes will be essential to confirm the in vivo relevance of our findings.
Taken together, these findings provide new insights into the molecular determinants of functional diversity of EV-A 2A proteases. By selectively analyzing evolutionarily relevant polymorphisms in the 2A protease, this study establishes a more biologically coherent classification framework and highlights the need to reassess traditional sequence-based methods when addressing functional and clinical diversity within closely related viral species.